6.27MMarket Cap
LossP/E TTM
PMCB Balance Sheet
You can check out the annual or quarterly balance sheets of PharmaCyte Biotech Inc here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.
FAQs
Which balance sheet metrics matter most when analyzing PMCB stock?
Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.
What is the difference between assets, liabilities, and shareholders' equity?
Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.
What is the difference between current and non-current items?
Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.
How Much Cash Does PharmaCyte Biotech Inc Have?
In its most recent quarterly, PharmaCyte Biotech Inc had 18.60M in cash and cash equivalents.
How Much Are PharmaCyte Biotech Inc's Total Liabilities?
PharmaCyte Biotech Inc reported 3.28M in total liabilities as of the latest reported quarter, including 2.91M in current liabilities and 363.00K in non-current liabilities.
What Are PharmaCyte Biotech Inc's Total Assets?
As of the latest reported quarter, PharmaCyte Biotech Inc's total assets were 46.75M, consisting of 37.42M in current assets and 9.33M in non-current assets.
How Much Shareholders' Equity Does PharmaCyte Biotech Inc Have?
PharmaCyte Biotech Inc reported 34.98M in total shareholders' equity as of the latest reported quarter.